Lucas Ward
Stock Analyst at Ascendiant Capital
(0)
# 5149
Out of 5,270 analysts
15
Total ratings
15.38%
Success rate
-53.49%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Aclarion | Maintains: Buy | 555 481 | 7.1 | 6674.65% | 3 | Nov 27, 2024 | |
LiqTech Intl | Maintains: Buy | 6 4 | 1.45 | 120.69% | 3 | Nov 25, 2024 | |
Vivos Therapeutics | Reiterates: Buy | 7 7 | 3.26 | 102.45% | 2 | Nov 20, 2024 | |
Heart Test Laborator... | Reiterates: Buy | 15 15 | 3.38 | 343.79% | 1 | Sep 23, 2024 | |
Cyclo Therapeutics | Maintains: Buy | 3 1 | 0.74 | 28.38% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 338 270 | 0.7 | 38471.43% | 2 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 144 | 1.7 | 8370.59% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2160 | n/a | n/a | 1 | Mar 6, 2023 |